HCV Research

Track Funding


HCV Funded Studies:

HCV Research

HIV Research

Hepatitis B & Viral Hepatitis" Studies

Liver Disease Research

Unknown Category Research


Charts & Data

Treatments

Clinical Trials

Cirrhosis, HCC & Transplant Research

Mental Health

Harm Reduction

Snapshot NIH-TransPlan for HCV Funding


 

 

PRESS RELEASE:
Millions of  Dollars Redirected HepCop has publicly denounced the National Institutes of Health (NIH) for spending millions of dollars budgeted for Hepatitis C (HCV) on other research agendas.

HCV Grants Allocated for HIV & HIV/HCV Research Projects

The NIH tells congress it's spending money on HCV research. NIH tells advocates it should be grateful HIV is funding HCV. Millions of dollars budgeted under the title of HCV research are awarded to determine such outcomes as, Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan ($676,058), Effects of HIV & Host Genetics in China ($645,840), and Nutritional Status In HIV Hispanic Drug Abusers ($660,216). 

Many of these studies may or may not mention HCV outcomes. But... be grateful...

HIV Grants
Grants Project Number Researcher Cost Project Title
NIAID N01AI25488-0-0-1 NO PI IDENTIFIED $1,030,509  Drug Dev for Opportunistic Inf. - Cell and Animal Model Development for Hep. C
$2,739,158 5R01DA011598-10 FREIER, SUSAN $660,216  Nutritional Status In HIV Hispanic Drug Abusers
1R01DA025932-01 FRIEDMANN, PETER $372,375  Drug Interactions in Substance Abusers with HIV Infection
1R01DA022914-01A2 ELHAMMER, AKE $676,058  Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan
NIMH 5R01MH073433-04 HERMANN, THOMAS $645,840  Neurobehavioral Effects of HIV & Host Genetics in China
       
Total HIV Grants $3,384,998  

HIV/HCV Grants

Grants Project Number Researcher Cost Project Title
NCI 1R41CA132397-01 DI BISCEGLIE, ADRIAN $168,000  Small Molecule Inhibitors of HBV/HCV Induced Liver Diseases
NCRR 2P41RR018522-06 KHAKOO, SALIM $52,949  HCV INFECTION AND HCV/HIV CO-INFECTION IN LIVER TISSUE
$408,999 5M01RR006192-15 BONA, ROBERT $1,842  HIV ON HEPATITIS C
5M01RR000065-46 SCHUPPAN, DETLEF $354,208  HCV-HIV COINFECTION: IMPACT OF IMMUNE DYSFUNCTION
NIAAA 1R21AA018009-01 SHAKED, ABRAHAM $173,738  A Novel Humanized Mouse Model for Studying HIV/HCV Co-Infection and Liver Disease
NIAID 5R43AI074255-02 KIEFT, JEFFREY $299,965  Multiplexed mRNA quanitification using self-circularizing RNA probes
$4,355,396 5K23AI066943-04 STERN, STEPHEN $121,770  Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis
5R01AI049168-08 HARRISON-FINDIK, DUYGU DEE $568,445  HCV Replication and Immune Response in HIV Coinfection
5K01AI070001-02 LOFFREDO, CHRISTOPHER $133,029  Risk factors and prediction of liver disease in HIV/HCV
5K23AI065319-04 MARKS, KRISTEN $131,490  Thrombocytopenia & HIV/HCV: Risk Factors & Treatment
5R21AI066957-02 ANTHONY, DONALD $189,456  Immunity of neoantigen response in HCV, HIV, and HCV-HIV
1Z01AI000390-25 FISHER, ROBERT $183,595  Therapeutic Strategies for the Management of HCV/HIV co- infection
1Z01AI000733-14 BERGER, EDWARD $294,681  Enveloped Virus Glycoprotein/receptor Interactions
5R01DA023405-02 BAUM, MARIANNA $521,643  HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants
3R01DA013806-09S1 STERLING, RICHARD $100,529  HIV HCV Coinfection Antiviral Therapy and Fibrosis
5R01DA019841-09 DASGUPTA, ASIM $866,282  Natural History of Hepatitis C Infection in HIV Disease
5R01DA024563-02 GHANY, MARC $378,489  INNATE IMMUNE DEFENSE AGAINST HCV and HIV: THE CHIMERIC MOUSE MODEL
5R01DA013806-09 STERLING, RICHARD $499,538  HIV HCV Coinfection Antiviral Therapy and Fibrosis
3R01DA023405-02S1 BAUM, MARIANNA $66,484  HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants
NIDCR 5M01RR006192-15 BONA, ROBERT $29  HIV ON HEPATITIS C
NIDDK 5R21DK077575-02 SULKOWSKI, MARK $181,300  Liver Disease Associated with HCV/HIV Coinfection Due to TRAIL
$226,146 1F32DK082155-01 RAY, STUART $44,846  The role of interferon-stimulated genes in antiviral immunity
NIGMS 2R01GM066978-05A2 OLTHOFF, KIM $303,961  Structure, dynamics, and function of the viroporins Vpu from HIV and p7 from HCV
$1,777,520 1R01GM087738-01A1 HUANG, TING-TING $342,938  Inhibition of HCV as an Opportunistic HIV Co-infection
5P01GM073732-03 DRAGIC, TATJANA $519,180  STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES
5P01GM073732-03 CATE, JAMIE $232,441  ROLE OF VIRAL IRES-RIBOSOME INTERACTIONS IN TRANSLATION
1R01GM085117-01 MOWEN, KERRI $379,000  The Role of Arginine Methyltransferases in Interferon Signaling
       
  Total HIV/HCV $7,109,828  

 


Source: National Institutes of Health Research Portfolio Online Reporting Tool (RePORT) Reports,
Data and Analyses of NIH Research Activities
Retrieved on March 18, 2009
http://report.nih.gov/rcdc/categories/ProjectSearch.aspx?FY=2008&DCat=Hepatitis+-+C

Permission is granted to use all information from this website in pursuit of ending NIH's "Trans-Plan" discriminatory practices against HCV research funding allocations. Please Credit: HCVets.com Educational Website & Support Forums for Military Related HCV Exposures.

Contact HepCop   
Email:
Staff